Abstract:Using an immunogenic nonmetastatic murine mammary adenocarci- noma (Dl-DMBA-3) induced in BALB/c mice by dimethylbenzanthra- cene, we have previously shown that splenocytes from tumor bearers have depressed lymphocyte responses to mitogens and antigens, including tumor-associated antigens. In addition, they display decreased natural killer and T-cell cytotoxic activities. Macrophages from tumor-bearing mice appear to be responsible for the suppression of T- and B-cell responses to concanavalin A, lipopolysaccharide, and tumor-associated antigens observed in tumor bearers. The appearance of these macro phages in the spleen tightly parallels the progressive growth of the tumor and the concomitant immunosuppression. Simultaneously high levels of macrophage progenitors were observed in blood, bone marrow, lung, and liver. A significant increase of colony-stimulating activity of the granu- locyte-macrophage lineage was detected in the sera from tumor-bearing mice. Higher levels of this colony-stimulating activity (CSA) were de tected in tumor cystic fluid as compared with the levels in serum. A tumor cell line established in vitro from the Dl-DMBA-3 in vivotumor produces high levels of a factor with CSA in culture supernatant fluids. Partial purification of the CSA from the tumor cell line supernatants was achieved using Centriceli Ultrafiltration and Sephacryl S-300 chromatog- raphy. These studies revealed that the molecular weight of the colony- stimulating-like factor is 32,000 to 35,000. The morphology of the colonies obtained in cultures using this factor is similar to that of the colonies that develop in the presence of granulocyte-macrophage colony- stimulating factor (GM-CSF) but not with macrophage colony-stimulat ing factor (M-CSF). CSA from tumor cell supernatants was neutralized by antiserum to GM-CSF but not with anti-M-CSF or anti-granulocyte colony-stimulating factor (G-CSF). Macrophages from bone marrow or peritoneal exÃºdalesfrom normal mice cultured with tumor supernatant for 2 to 3 days strongly inhibit normal splenocyte responses to concana valin A and lipopolysaccharide. The data suggest that the tumor releases a GM-CSF that alters the hemopoietic system and induces or expands macrophages, which exert a suppressive function on the immune system of tumor-bearing mice. presser functions appear to play important roles in the regulation of a great variety of in vivo and in vitro immunolog- ical phenomena (1-7). Exactly how those cells are induced and/ or expanded in the tumor-bearing host has not been clearly elucidated. Moreover, it is not known whether tumor products and/or host products directly or indirectly cause the observed immunosuppression. Using an immunogenic nonmetastatic murine mammary ad- enocarcinoma induced in BALB/c mice by dimethylbenzan- thracene (Dl-DMBA-3), we have previously observed a gener alized immunosuppressed state as determined by diminished proliferative responses to mitogens and antigens, decreased natural killer and cytolytic T-lymphocyte activities, and other criteria (8-11). In addition, there is an induction of macro phages in the spleen of tumor bearers which have a Mac 1*2+ phenotype. These macrophages appear to be responsible for the observed immunosuppression via various mechanisms, which include release of prostaglandins and aberrant presentation of antigens in the context of I-E molecules to T-suppressor cells (12). An investigation was undertaken to elucidate the mecha nism of induction of these suppressor macrophages that are in the spleens of mammary tumor-bearing mice. In this paper we present evidence that there is a systemic increase of granulocyte and macrophage progenitors associated with an elevated col ony-stimulating activity in the serum and tumor cystic fluid of tumor bearers. Furthermore, supernatants of tumor cells grown in vitro release high levels of GM-CSF' as defined by bioassays, biochemistry, and neutralization with antiserum to this factor. The results indicate that the tumor constitutively produces GM- CSF, which induces cells of the macrophage lineage that alters nonspecific and specific immune responses in tumor-bearing mice.

The Involvement of Macrophage Colony Stimulating Factor on Protein Hydrolysate Injection Mediated Hematopoietic Function Improvement

Shenfu Injection Protects Against Myelosuppression from Chemotherapy

An Unbalanced Monocyte Macrophage Polarization In The Bone Marrow Microenvironment Of Patients With Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Can 29kda Rhgm-Csf Expressed by Silkworm Pupae Bioreactor Bring into Effect As Active Cytokine Through Orally Administration?

Acceleration of Hematopoietic Recovery of Chemotherapeutically Lesioned Mice by Recombinant Human Macrophage Colony Stimulating Factor Expressed in Silkworm

Enhancing Effects of Silkworm Expressed Recombinant Human Macrophage Colony-Stimulating Factor on Hematopoietic Recovery of Irradiation-Injured Mice.

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

Engineering a Pharmacologically Superior Form of Granulocyte-Colony-stimulating Factor by Fusion with Gelatin-Like-protein Polymer.

ZhenQi FuZheng Formula Improves Mouse Hematopoietic Function after Cyclophosphamide-Induced Damage via Enhancing Macrophage Colony-Stimulating Factor Concentrations

Cdc42 Inhibitor ML141 Enhances G-CSF-induced Hematopoietic Stem and Progenitor Cell Mobilization.

Cytokine Cocktail Promotes Alveolar Macrophage Reconstitution and Functional Maturation in a Murine Model of Haploidentical Bone Marrow Transplantation

Design of Recombinant Stem Cell Factor–macrophage Colony Stimulating Factor Fusion Proteins and Their Biological Activity in Vitro

Along the gut-bone marrow signaling pathway: Use of longan polysaccharides to regenerate blood cell after chemotherapy-induced myelosuppression

Immune Responses of M-Csf-r Dna Vaccine and Its Effects on Hematopoiesis in Mice

Synthesis of Osteogenic Growth Peptide and Its Synergetic Effect with Granulocyte Colony Stimulating Factor.

Effect of synthetic osteogenic growth peptide on hematopoiesis in normal mice and assay of its hematological activity in vitro

Interventional Effect of Donkey Bone Collagen Peptide Iron Chelate on Cyclophosphamide Induced Immunosuppressive Mice

Expansion Of Immunoregulatory Macrophages By Granulocyte-Macrophage Colony-Stimulating Factor Derived From A Murine Mammary-Tumor

Impact of macrophage differentiation on hematopoietic function enhancement by Shenzhu ErKang Syrup

A Novel Thrombopoietin–stem‐cell Factor Fusion Protein Possesses Enhanced Potential in Stimulating Megakaryocyte Proliferation and Differentiation

Improved Hematopoiesis Reconstitution of Mice after Large Dose Chemotherapy by Using PF4 Gene Transfected Attenuated Salmonella Typhmuriumas Orally